Advertisement
Advertisement
U.S. Markets open in 9 hrs 18 mins
Advertisement
Advertisement
Advertisement
Advertisement

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.5000-0.3500 (-18.92%)
At close: 04:00PM EST
1.4600 -0.04 (-2.67%)
After hours: 07:59PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close1.8500
Open1.6400
Bid1.4600 x 1400
Ask1.4700 x 1000
Day's Range1.4800 - 1.7800
52 Week Range0.8600 - 4.2700
Volume4,328,963
Avg. Volume889,377
Market Cap42.191M
Beta (5Y Monthly)0.07
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    X4 Pharmaceuticals Announces Positive Top-Line Results from 4WHIM Global, Pivotal Phase 3 Trial of Once-Daily, Oral Mavorixafor in WHIM Syndrome

    4WHIM trial meets primary endpoint and first key secondary endpoint, with mavorixafor achieving statistically significant and clinically relevant longer times above threshold levels for both absolute neutrophil (P <0.0001) and absolute lymphocyte counts (P<0.0001) versus placebo Mavorixafor was generally well tolerated in the trial Company to host a conference call and webcast today at 4:30 p.m. ET BOSTON, Nov. 29, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals (Nasdaq: XFOR), a leader in the disco

  • GlobeNewswire

    X4 Pharmaceuticals to Present at Stifel Healthcare Conference

    BOSTON, Nov. 08, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with diseases of the immune system, today announced that management will participate in a fireside chat at the Stifel Healthcare Conference on Tuesday, November 15, 2022. Details are as follows: Conference: Stifel Healthcare ConferenceFormat: Fireside ChatDate: Tuesday, November 15, 2022Time: 3:00 PM ETWebcast Link A l

  • GlobeNewswire

    X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    BOSTON, Nov. 04, 2022 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of novel small-molecule therapeutics to benefit people with diseases of the immune system, today announced that, effective on November 3, 2022, the company issued inducement awards to new employees under the X4 Pharmaceuticals, Inc. 2019 Inducement Equity Incentive Plan (the “2019 Inducement Plan”). The 2019 Inducement Plan is used exclusively for the grant of equity award

Advertisement
Advertisement